维普中文期刊产品整合服务
19篇 您的检索式:作者名="Haserlat"
    题名 作者 年代 出处 被引量
1Epidermal growth factor recep- tor mutations and gene amplification in non - small - cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials 显示文摘Bell DW Lynch TJ Haserlat SM 2005J Clin Oncol2005,23,31:1
2Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer:molecular analysis of the IDEAL/INTACT gefitinib trials显示文摘Bell DW Lynch TJ Haserlat SM ct al 0,,31:1
3Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer : molecular analysis of the IDEAL/INTACT gefitinib trials 显示文摘Bell DW Lynch TJ Haserlat SM 2005J Clin 0ncol2005,2331,:1
4Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer gefitinib显示文摘Lynch TJ Bell DW Sordella R Gurubhagavatula S Okimoto RA Brannigan BW Harris PL Haserlat SM Supko JG Haluska FG Louis DN Christiani DC Settleman J Haber DA 0,,:1
5Epidermal growth factorreceptor mutations and gene amplification in non-small-cell lungcancer:molecular analysis of the IDEAL/INTACT gefitinib trials显示文摘Bell DW Lynch TJ Haserlat SM 2005J Clin Oncol2005,23,31:1
6Epidermal growthfactor receptor mutations and gene amplification in non-small-cell lung cancer:molecular analysis of the IDEAL/INTACT gefitinib trials显示文摘Bell DW Lynch TJ Haserlat SM 2005J Clin Oncol2005,23,31:1
7Epidermal growth factor receptor mutations and gene amplification in non-small- cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials 显示文摘Bell D W Lynch T J Haserlat S M 2005J Clin Oncol2005,23,31:1
8Epidermal growth factor receptor mutations and gene amplification in non- small-cell lung cancer: molecular analysis of the IDEAL/ INTACT gefitinib trials 显示文摘Bell DW Lynch TJ Haserlat SM 2005J Clin Oncol2005,23,31:1
9Epidermal growth factor receptor mutations and gene amplification in non - small cell lung cancer:molecular analysis of the IDEAL/INTACT gefitinib trials 显示文摘Bell DW Lynch TJ Haserlat SM 2005J Clin 0ncol2005,23,:1
10Epidermal growth factor receptor mutations and gene amplification in non-small cell lung cancer:molecular analysis of the IDEAL/INTACT gefitinib trials显示文摘BELL D W LYNCH T J HASERLAT S M 2005J Clin Oncol2005,1123,31:1
11Epidermal growth factor receptor mutations and gene amplification in non-small- cell lung cancer: molecular analysis of the IDEAL/INTACT ge- fitinib trials 显示文摘Bell D W Lynch T J Haserlat S M 2005Journal of Clinical Oncology2005,23,31:1
12Epidermal growth factor receptor mutations and gene amplification in non - small -cell lung cancer:Molecular analysis of the IDEAL/INTACT gefitinib trials显示文摘Daphne W Bell Thomas J Lynch Sara M Haserlat 2005J Clin Oncol2005,23,:1
13Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer:molecular analysis of the IDEAL/INTACT gefitinib trials显示文摘Bell DW Lynch TJ Haserlat SM 2005J Clin Oncol2005,23,31:1
14Epidermal growth factor receptor mutations and gene amplification in non-small- cell lung cancer: Molecular analysis of the IDEAL/INTACT Gefitinib trials 显示文摘Bell DW Lynch TJ Haserlat SM 2005J Clin Oncol2005,23,31:1
15Epidermal growth factor receptor mutations and gene amplification in lion small- cell lung caner:mohedar analysis of the 1DEAL/INTACT gefitinib mals 显示文摘Bell D W Lynch T J Haserlat S M 2010J Clin Oncol2010,23,31:1
16Epidermal growth factor receptor mutation and gene amplification in non-smallcell lung cancer:molecular analysis of the IDEAL/INTACT gefitinib trials显示文摘Bell DW Lynch TJ Haserlat SM 2005J Clin Oncol2005,23,31:1
17Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer:molecular analysis of the IDEAL/INTACT gefitinib trials显示文摘Bell DW Lynch TJ Haserlat SM 0,,31:1
18Epidermal growth factor receptor mutations and gene amplification in non-small cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials显示文摘Bell D W Lynch T J Haserlat S M 2005J Clin Oncol2005,23,31:1
19Epidermal growth factor receptor mutations and gene amplification in non-small cell lung cancer: molecular analysis of IDEAL/INTACT gefitinib trials显示文摘Bell DW Lynch TJ Haserlat SM 2005J C/in Oncol2005,23,31:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费